Zehnatx
1 known investors
Zehna Therapeutics is an early-stage biotech company developing non-bactericidal small-molecule inhibitors of gut microbial enzymes, with lead compounds targeting CutC lyase to lower TMAO levels. Its work focuses on treating cardiometabolic and chronic diseases, with chronic kidney disease as its lead indication.
Founders & leadership
CV
Camilla V. SimpsonChief Executive Officer
RM
Robert Matunas, PhDHead of CMC and Nonclinical Sciences
MB
Mike Bishop, PhDHead of Early Development and Medicinal Chemistry
Investors · 1
Competitors · 7
by search overlapSionnatx19 shared keywordsSionna Therapeutics is a biopharmaceutical company founded in 2019 that develops small-molecule therapies for cystic fibrosis by targeting and stabilizing NBD1, the domain of the CFTR protein where the common ΔF508 mutation occurs. It is advancing a portfolio of NBD1 stabilizers and complementary CFTR modulators intended to be used in combination to normalize CFTR function in CF patients.
Serna Bio10 shared keywordsSerna builds a platform to unlock the transcriptome as a drug target for drug discovery. The company integrates technology and biology to change drug discovery processes.
Syrna Therapeutics9 shared keywordsSyrna Therapeutics is a biotech company developing small-molecule covalent translation inhibitors that bind and modify structured domains in the mRNA of disease-causing proteins to block their expression. It uses a 3D structure-guided drug discovery platform, with lead programs in immunology and neurodegeneration and a broader pipeline spanning metabolic disease and oncology.
ロゴマーク：AIRNA9 shared keywordsAIRNA develops RNA editing therapeutics aimed at providing functional cures for patients with rare diseases and common conditions. The company works in the genetic medicines and biotech space.
Therna9 shared keywordsTherna Biosciences designs programmable RNA therapeutics by combining RNA foundation models (its RNA-Logix platform) with proprietary experimental datasets. The company develops medicines for cardiovascular, metabolic, and immunological diseases, including single-patient programs for ultra-rare conditions.
Cleveland Clinic8 shared keywordsCleveland Clinic is an academic medical center providing patient care, including virtual visits, primary care, urgent care, and emergency services, along with medical education and research programs. It also offers resources for physicians and healthcare professionals, including referrals, clinical trials, and continuing education.
Doximity8 shared keywordsDoximity is the largest verified network of healthcare professionals in the U.S., connecting physicians, PAs, NPs, pharmacists, and medical students across specialties and care settings. The platform provides mobile-first tools for clinical communication, collaboration, and workflow optimization.
Companies competing with Zehnatx for the same Google search keywords, organic and paid, via search-intersection analysis.
Frequently asked questions
- What does Zehnatx do?
- Zehna Therapeutics is an early-stage biotech company developing non-bactericidal small-molecule inhibitors of gut microbial enzymes, with lead compounds targeting CutC lyase to lower TMAO levels. Its work focuses on treating cardiometabolic and chronic diseases, with chronic kidney disease as its lead indication.
- Who are Zehnatx's investors?
- Zehnatx's investors include JobsOhio Ventures.